Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease

Figure 6 Correlation between A-W-B levels with liver proton density fat fraction and the severity of metabolic-associated fatty liver disease. A: The prediction model combining atherogenic index of plasma, waist circumference, and body mass index (A-W-B) level was strongly and positively associated with liver proton density fat fraction (PDFF) (r = 0.630, P < 0.001); B: Compared with the control group, ^bP < 0.001; compared with the mild group, ^aP < 0.01. MAFLD: Metabolic-associated fatty liver disease.